Navigation Links
Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
Date:12/5/2010

NEW YORK, Dec. 5, 2010 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) today announced that its Board of Directors has elected Ian C. Read, 57, currently head of the Company's global biopharmaceutical operations, as President, Chief Executive Officer and Director. Mr. Read succeeds Jeffrey B. Kindler, who has retired from the Company.  

(Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO)

The Board's Lead Independent Director, Constance J. Horner, said, "In 2006, Jeff Kindler took on the challenge of transforming Pfizer in the face of enormous changes in the global health care marketplace and significant patent expirations of major products, including Lipitor.  Acting with the highest level of ethics and professionalism, he moved aggressively to drive change at the Company, including putting new, more focused and agile business units in place, building and enhancing world class compliance systems, recruiting talented new leaders, and refocusing and streamlining operations in every part of the world.  He also led the acquisition of Wyeth, which brought the Company valuable in-line and pipeline products and capabilities in attractive growth areas, including vaccines and biologics.  Due to the efforts of Jeff, the executive leadership team and Pfizer's talented employees around the world, the Company is now a stronger, more diversified and more focused company."      

Mr. Kindler commented, "My nearly nine years at Pfizer and, particularly the last four and a half as CEO, have been extremely exciting and rewarding.  I feel our team can proudly boast of some transformational accomplishments.  However, the combination of meeting the requirements of our many stakeholders around the world and the 24/7 nature of my responsibilities, has made this period extremely demanding on me personally.  Now that we are ab
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... CHAPEL HILL, N.C. , July 2, 2015 ... their own employees to capture critical product and ... there are many benefits to employee-based studies, it ... to leverage their own internal employees to capture ... recent study by benchmarking firm, Best Practices, LLC, ...
(Date:7/2/2015)... 2, 2015  New product launches are critical events ... in educating thought leaders about new products, Medical Affairs ... how well a new therapy performs at launch. ... and consulting leader Best Practices, LLC, critical aspects of ... on are early stage thought leader (TL) interaction, successful ...
(Date:7/2/2015)... July 2, 2015 Releases of ... Aedes aegypti , , reduced the dengue ... Brazil by 95%, well below the modelled ... http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal PLOS Neglected Tropical ... Oxitec,s genetically engineered mosquitoes. The results showed that in ...
Breaking Medicine Technology:Leveraging Employee Insights to Produce Cutting-Edge Market Research 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
... The American College of Surgeons (ACS) today announced its ... respected National Surgical Quality Improvement Program (ACS NSQIP®). The ... initiative launched today, an effort to raise awareness ... disease management that can help improve the quality and ...
... 2011 PharmaNet Development Group, Inc., an inVentiv ... development services to pharmaceutical, biotechnology, generic drug and ... appointed George Scott, PhD, as Vice President, Bioanalytical ... leadership for PharmaNet,s GLP-compliant bioanalytical laboratories in the ...
Cached Medicine Technology:American College of Surgeons Announces Goal to Enlist 1,000 Hospitals to its National Surgical Quality Improvement Program 2American College of Surgeons Announces Goal to Enlist 1,000 Hospitals to its National Surgical Quality Improvement Program 3American College of Surgeons Announces Goal to Enlist 1,000 Hospitals to its National Surgical Quality Improvement Program 4American College of Surgeons Announces Goal to Enlist 1,000 Hospitals to its National Surgical Quality Improvement Program 5PharmaNet Names Dr. George Scott Vice President of Bioanalytical Services 2
(Date:7/3/2015)... NY (PRWEB) , ... July 03, 2015 , ... ... Learning Lecture took place on June 25, 2015 at 1:00pm. The Association welcomed ... explored issues pertaining to injured bicyclists and practical points of investigating these types ...
(Date:7/3/2015)... ... 03, 2015 , ... First Choice Emergency Room , the largest network ... as the new Medical Director of its Frisco facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is ... dresses similar to those of celebrities will have the opportunity to get 10% discount ... This ensures that people do not have to use coupon codes or remember redemption ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on June 22, ... emphatically declared a war on obesity in the United States. , "Obesity is one ... the magnitude of this discovery. For that reason, I am declaring, along with my ...
(Date:7/2/2015)... ... ... With summer in full swing, Americans are flocking to Canada’s many lakes to reel in ... in the world, and it’s easy to understand why. From the Pacific Northwest Coast of ... Recreational fishing is a huge industry, and Americans make up the vast majority of anglers ...
Breaking Medicine News(10 mins):Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... to come, WASHINGTON, Feb. 6 Across five ... people and supplies,are flowing in to provide care to ... 5. In every tornado-affected,community, Red Cross workers are on ... rescue workers, and lending emotional support to,all., More ...
... Kan., Feb. 6 Mediware Information,Systems (Nasdaq: MEDW ... to,the board of directors. The Company also announced that ... 16 years of valuable,service., Mr. Coelho, age 64, ... technology consumer electronic or medical device companies. He is ...
... From early communication,about product changes to ... products and processes at two-thirds of companies,according ... LLC,s Global Benchmarking,Council. Incorporating VOC data in ... the customer service function within the call ...
... 2008 Although scientists have speculated over the negative ... that certain environmental toxins may disrupt the normal growth ... toxins, such as the mycoestrogen zearalenone (ZEA) produced by ... the environment, have properties similar to the female reproductive ...
... Rising Medical Solutions, Inc.,(Rising), a leading ... Private Company Index (PCI) "Top Growth Company" ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080206/AQW030LOGO-b ), (Logo: ... by Entrex, Inc. ( http://www.entrex.net ), is ...
... Hospital is embarking on an expanded major clinical trial involving ... to determine if the combined treatment is more effective than ... , The clinical trial is part of a $9 million ... Ford to study the effectiveness of gene therapy to treat ...
Cached Medicine News:Health News:Massive American Red Cross Tornado Relief Effort Spans Five States 2Health News:Philip Coelho Joins Mediware Board 2Health News:Philip Coelho Joins Mediware Board 3Health News:Customer Experience Conference, Feb. 25-27: Sharing New Insights on Winning Customer Loyalty 2Health News:New study suggests link between environmental toxins and early onset puberty in girls 2Health News:Rising Medical Solutions, Inc. Ranks Fifth on the Private Company Index (PCI) 'Top Growth Companies' List 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 3
... standards set by the new SZ61 and ... "Comfort View eyepiece design and the accessible, ... fatiguing than ever before. The compact design ... field as well as clarity, detail, and ...
The modular, high-end stereomicroscope; meets even the most critical demands in research and quality control provides high-contrast images with excellent depth of field and color fidelity...
A compact stereomicroscope that is immediately ready for operation and extremely easy to use. Focused on the essential performance features, the Stemi DV4 design concept provides optimum utility....
10:1 Zoom Ratio - The parallel optical system of the SMZ-1000 has a 10:1 zoom with clickstops at 1X intervals. It features a zoom range of 0.8X to 8.0X and total magnification (depending on eyepieces...
Medicine Products: